ZBIO logo

Zenas BioPharma (ZBIO)

Profile

Full Name

Zenas BioPharma, Inc.

Ticker Symbol

ZBIO

Exchange

NASDAQ

Country

United States

IPO

September 13, 2024

Indexes

Not included

Employees

130

Key Details

Price

$9.95(-0.70%)

Market cap

$381.26M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.00M(-90.00% YoY)

Annual EPS

-$11.89(-457.80% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 Wedbush
Outperform
Mar 12, 25 HC Wainwright & Co.
Buy
Mar 12, 25 Guggenheim
Buy
Feb 4, 25 Wolfe Research
Outperform
Dec 16, 24 HC Wainwright & Co.
Buy
Dec 11, 24 Morgan Stanley
Overweight
Dec 3, 24 Guggenheim
Buy

Institutional Ownership

  • What is the ticker symbol for Zenas BioPharma?
  • Does Zenas BioPharma pay dividends?
  • What sector is Zenas BioPharma in?
  • What industry is Zenas BioPharma in?
  • What country is Zenas BioPharma based in?
  • When did Zenas BioPharma go public?
  • Is Zenas BioPharma in the S&P 500?
  • Is Zenas BioPharma in the NASDAQ 100?
  • Is Zenas BioPharma in the Dow Jones?
  • When was Zenas BioPharma's last earnings report?
  • When does Zenas BioPharma report earnings?
  • Should I buy Zenas BioPharma stock now?

What is the ticker symbol for Zenas BioPharma?

The ticker symbol for Zenas BioPharma is NASDAQ:ZBIO

Does Zenas BioPharma pay dividends?

No, Zenas BioPharma does not pay dividends

What sector is Zenas BioPharma in?

Zenas BioPharma is in the Healthcare sector

What industry is Zenas BioPharma in?

Zenas BioPharma is in the Biotechnology industry

What country is Zenas BioPharma based in?

Zenas BioPharma is headquartered in United States

When did Zenas BioPharma go public?

Zenas BioPharma's initial public offering (IPO) was on September 13, 2024

Is Zenas BioPharma in the S&P 500?

No, Zenas BioPharma is not included in the S&P 500 index

Is Zenas BioPharma in the NASDAQ 100?

No, Zenas BioPharma is not included in the NASDAQ 100 index

Is Zenas BioPharma in the Dow Jones?

No, Zenas BioPharma is not included in the Dow Jones index

When was Zenas BioPharma's last earnings report?

Zenas BioPharma's most recent earnings report was on Nov 12, 2024

When does Zenas BioPharma report earnings?

The next expected earnings date for Zenas BioPharma is May 30, 2025

Should I buy Zenas BioPharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page